the market?
EXACT Sciences Corp
NASDAQ: EXAS
12.90
0.07
(0.55%)
| Today's Open | $12.87 |
|---|---|
| Previous Close | $12.83 |
| Daily Range | $12.60 - $13.16 |
| 52-Week Range | $6.93 - $14.42 |
| Market Cap | $826.8M |
| P/E Ratio | -14.92 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 1,310,875 |
| Average Daily Volume | 1,123,182 |
| Current FY EPS | -$0.74 |
How do you think EXAS
will perform against the market?
Top EXAS Bull/Bear Pitches
NHWeston (9.85)
Submitted
June 1, 2011
Exact Sciences stakes its future on a pioneering and extremely promising gambit - replacing the colonoscopy with a highly-reliable, completely non-invasive test for rectal and intestinal cancer. Its t … More
zzlangerhans (< 20)
Submitted
October 24, 2011
Exact's share price seems to be getting ahead of itself yet again as the Cologuard trial enters the early stages of an enrollment process that will likely extend at least another 12 months. That means … More
News & Commentary
Here's What This Top-Earning Billionaire Has Been Buying
It can pay off to keep an eye on strong performers.Exact Sciences Floats New Stock Issue
The company aims to raise nearly $64 million from the offering.Exact Sciences Submits Final Module and Completes Cologuard Premarket Approval Application to FDA, E
Why Exact Sciences Is Poised to Underperform
Market-lagging returns could be written in this 2-Star.Sector
Healthcare
Industry
Drugs
EXACT Sciences Corp (EXAS) Description
An applied genomics company that develops proprietary DNA-based technologies for use in the detection of cancer. Website: http://www.exactsciences.com/
